3 unknown, 2 completed, 2 withdrawn, 1 terminated. 5 Phase 2, 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Withdrawn 1 |
Follow temoporfin: new trials by email Literature Review of temoporfin trials Research Report on temoporfin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers Temoporfin - Cholangiocarcinoma, Tumor | Phase 2 | Completed | Chinese University of Hong Kong | 10 | 2014-03-28 | 2023-08-22 |
| Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery Temoporfin, Therapeutic Conventional Surgery, Photodynamic Therapy - Recurrent Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma | Phase 1 | Completed | Roswell Park Cancer Institute | 8 | 2014-02-21 | 2022-07-22 |
| Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer photodynamic therapy, therapeutic conventional surgery, laboratory biomarker analysis - Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2013-12-01 | 2014-09-03 | |
| Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer Temoporfin - Carcinoma, Non-Small-Cell-Lung | Phase 1 | Withdrawn | University of Arkansas | 2012-07-01 | 2014-01-15 | |
| Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers Temoporfin, Medical diode laser emitting light at a wavelength of 652 nm. (Ceralas PDT 652, CeramOptec GmbH) - Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Terminated | University of Arkansas | 1 | 2010-11-01 | 2012-12-03 |
| FoscanĀ®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma FOSCAN - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Ministry of Health, Malaysia | 66 | 2009-01-01 | 2011-07-08 |
| Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma Temoporfin - Non-curative Resectable Bile Duct Carcinoma | Phase 2 | Unknown | University of Salzburg | 35 | 2006-01-01 | 2009-11-18 |
| Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy temoporfin - Head and Neck Cancer | Phase 2 | Unknown | Quintiles, Inc. | 75 | 1998-10-01 | 2013-12-19 |
Squamous Cell Carcinoma of Head and Neck (3) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Squamous Cell (2) · Head and Neck Neoplasms (2) · Adenocarcinoma (1) · Carcinoma, Large Cell (1) · Cholangiocarcinoma (1) · Klatskin Tumor (1) · Lung Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Neoplasms (1) · Recurrence (1) · Salivary Gland Neoplasms (1) · Tongue Neoplasms (1)
Roswell Park Cancer Institute (2) · University of Arkansas (2) · Chinese University of Hong Kong (1) · Ministry of Health, Malaysia (1) · Quintiles, Inc. (1) · University of Salzburg (1)
United States (4) · Austria (1) · Germany (1) · Hong Kong (1) · Malaysia (1)
Barbara Larson (1) · Chukwumere Nwogu (1) · Frieder Berr, Prof., MD (1) · Hassan Arshad, MD (1) · Lohse A, Prof., MD (1) · Mary E Meek, MD (1) · Yoke Yeow Yap, MD (1)